文献速递口腔修复与种植

高维生素D血症与不良种植牙结局相关:一项回顾性病例对照研究

Hypervitaminosis D is correlated with adverse dental implant outcomes: A retrospective case-control study.
PubMed 文献 · J Dent · 2024-06-18

结果发现,血液25(OH)D水平>70 ng/mL的患者种植体失败或严重边缘骨吸收的风险是中间水平(>30且≤70 ng/mL)患者的21.1倍,高维生素D血症组种植体19年生存概率为73.7%(95%CI:56.5-84.5%),而中间水平组为95%(95%CI:88.3-97.9%),且高维生素D血症影响在上颌种植体更明显。结论提示血液25(OH)D>70 ng/mL与不良种植结局相关,尤其在上颌。

要点

  • 血液25(OH)D>70 ng/mL时种植体失败或严重骨吸收风险增加21.1倍。
  • 高维生素D血症组19年种植体生存概率73.7%,低于中间水平组的95%。
  • 高维生素D血症对种植体的不良影响在上颌更明显,下颌不明显。

核心结论

  • 血液25(OH)D水平>70 ng/mL与不良种植结局相关,包括种植体失败和种植体周围骨吸收,尤其在上颌。

主要发现

  • 血液25(OH)D>70 ng/mL的患者种植体失败或严重种植体周围骨吸收的风险是中间水平(>30且≤70 ng/mL)患者的21.1倍。
  • Kaplan-Meier生存分析显示,高维生素D血症组种植体术后19年生存概率为73.7%(95%CI:56.5-84.5%),中间水平组为95%(95%CI:88.3-97.9%)。
  • 高维生素D血症组种植体骨丢失速度快于中间水平组。
  • 上述结果仅见于血液25(OH)D水平升高的患者队列,未在服用维生素D补充剂的患者中观察到。
  • 高维生素D血症的影响在上颌种植体中更明显,下颌种植体中不明显。

关键数值与推荐

  • 血液25(OH)D水平>70 ng/mL定义为高维生素D血症,中间水平为>30且≤70 ng/mL。
  • 高维生素D血症患者种植体失败或严重骨吸收风险增加21.1倍。
  • 高维生素D血症组种植体19年生存概率73.7%(95%CI:56.5-84.5%),中间水平组95%(95%CI:88.3-97.9%)。

临床怎么用

  • 对于种植牙患者,应关注血液25(OH)D水平,尤其当水平>70 ng/mL时需警惕种植体失败和骨吸收风险。
  • 高维生素D血症可能是一个先前未识别的种植体并发症风险因素,需进一步研究以阐明机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate vitamin-D levels effect on the survival/success and on marginal bone levels of dental implants. METHODS: Patients with peri-implant disease and healthy control patients with functionally loaded dental implants were included in this retrospective case-control study. Forty patients with 201 implants were in the diseased-cohort, while thirty-three patients with 90 implants were in the control-cohort. Patient blood 25(OH)D levels were assessed through quantitative blood test. The correlation between abnormal 25(OH)D levels and disease status of each patient was assessed using Fisher's exact tests. The correlation of each implant's outcomes with vitamin-D status was assessed using Kaplan-Meier survival analysis and Mann-Whitney U tests. RESULTS: Patients with blood 25(OH)D levels >70 ng/mL (hypervitaminosis-D) had a 21.1-fold increase in the risk of implant failure or severe peri-implant bone loss regarding patients with intermediate (>30, ≤70 ng/mL) levels. Kaplan-Meier survival analysis revealed that implants in the hypervitaminosis-D cohort had a survival probability of 73.7 % (95 % CI:56.5-84.5 %) at 19-years after surgery, compared to 95 % for implants in patients with intermediate 25(OH)D levels (95 % CI:88.3-97.9 %). Additionally, implants in the hypervitaminosis-D cohort lost bone faster than implants in the intermediate cohort. These results were specific to the patient cohort with elevated blood 25(OH)D levels and not observed in patients taking vitamin-D supplementation. The impact of hypervitaminosis-D was enriched for implants in the maxilla, and not as apparent for implants in the mandible. CONCLUSIONS: Blood 25(OH)D levels >70 ng/mL were correlated with adverse implant outcomes, including implant failure and peri-implant bone loss, especially in the maxilla. CLINICAL RELEVANCE: These results suggest that hypervitaminosis D may be a previously unidentified risk factor for dental implant complications and should be further investigated to elucidate the underlying mechanism.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Cheng YC, Murcko L, Benalcazar-Jalkh EB, et al. Hypervitaminosis D is correlated with adverse dental implant outcomes: A retrospective case-control study. J Dent. 2024. PMID: 38901822. doi:10.1016/j.jdent.2024.105137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。